Table 3.
Microbiologic details of PEG-tube insertion site infections in cancer patients
| Types of infection, n = 75 | Organisms | N (%) |
|---|---|---|
| Monomicrobial | Total | 39 (52.0) |
| Staphylococcus aureus (methicillin susceptible) | 11 (28.2) | |
| Staphylococcus aureus (methicillin resistant) | 8 (20.5) | |
| Coagulase-negative staphylococci | 2 (5.1) | |
| Pseudomonas aeruginosa | 7 (17.9) | |
| Streptococcus species | 4 (10.3) | |
| Serratia marcescens | 3 (7.7) | |
| Candida species | 4 (10.3) | |
| Polymicrobial | Total | 36 (48.0) |
| Staphylococcus aureus (methicillin susceptible) | 21 (58.3) | |
| Staphylococcus aureus (methicillin resistant) | 12 (33.3) | |
| Streptococcus species | 7 (19.4) | |
| Enterococcus species | 8 (22.2) | |
| Escherichia coli | 13 (36.1) | |
| Other Enterobacteriaceae | 16 (44.4) | |
| Pseudomonas aeruginosa | 17 (47.2) | |
| Stenotrophomonas maltophilia | 2 (5.6) | |
| Acinetobacter species | 1 (2.8) | |
| Candida species | 18 (50.0) |